Home » Stocks » LIVN

LivaNova PLC (LIVN)

Stock Price: $68.11 USD -0.48 (-0.70%)
Updated Jan 15, 2021 4:00 PM EST - Market closed
Market Cap 3.33B
Revenue (ttm) 952.28M
Net Income (ttm) -208.41M
Shares Out 48.65M
EPS (ttm) -4.30
PE Ratio n/a
Forward PE 35.09
Dividend n/a
Dividend Yield n/a
Trading Day January 15
Last Price $68.11
Previous Close $68.59
Change ($) -0.48
Change (%) -0.70%
Day's Open 68.01
Day's Range 67.04 - 69.48
Day's Volume 439,373
52-Week Range 34.22 - 76.49

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
Seeking Alpha - 1 month ago

LivaNova has upside levers in place to drive top-line growth over the coming periods, with a sequential growth pattern from Q2 to Q3. The company recently sold its heart valves arm, removing t...

Business Wire - 1 month ago

LONDON--(BUSINESS WIRE)---- $LIVN--LivaNova PLC today announced a series of enhancements to the Company's governance.

Business Wire - 1 month ago

LONDON--(BUSINESS WIRE)---- $LIVN--LivaNova announced it will host “Updates and Advances in Neuromodulation,” a satellite symposium at AES2020 on Dec. 6, featuring leading clinicians.

Business Wire - 1 month ago

LONDON--(BUSINESS WIRE)---- $LIVN--LivaNova and Gyrus have entered into an agreement whereby entities funded and controlled by Gyrus will acquire the LivaNova heart valve business.

Business Wire - 1 month ago

LONDON--(BUSINESS WIRE)---- $LIVN--LivaNova PLC announced CEO Damien McDonald will participate in discussions at the Berenberg European Conference 2020 on December 2.

Business Wire - 1 month ago

LONDON--(BUSINESS WIRE)---- $LIVN--LivaNova announced CEO Damien McDonald will participate in discussions at the Piper Sandler 32nd Annual Virtual Healthcare Conference Nov. 30-Dec. 3.

Business Wire - 2 months ago

LONDON--(BUSINESS WIRE)---- $LIVN--LivaNova today announced Damien McDonald, CEO, will present at the Stifel 2020 Virtual Healthcare Conference on Tuesday, November 17 at 10:40 a.m. ET.

Benzinga - 2 months ago

Shares of LivaNova (NASDAQ:LIVN) were unchanged after the company reported Q3 results.

Zacks Investment Research - 2 months ago

LivaNova (LIVN) delivered earnings and revenue surprises of 80.95% and 8.29%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

Business Wire - 2 months ago

LONDON--(BUSINESS WIRE)---- $LIVN--LivaNova PLC (NASDAQ: LIVN), a market-leading medical technology and innovation company, today reported results for the quarter ended Sept. 30, 2020.

Zacks Investment Research - 2 months ago

LivaNova (LIVN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Business Wire - 3 months ago

LONDON--(BUSINESS WIRE)---- $LIVN--LivaNova PLC today confirmed receipt of a letter from PrimeStone Capital LLP to its Board of Directors and issued a statement.

Business Wire - 3 months ago

LONDON--(BUSINESS WIRE)---- $LIVN--LivaNova presented Perceval and Perceval Plus data at the 34th Annual Meeting of the European Association for Cardio-Thoracic Surgery (EACTS).

Business Wire - 3 months ago

LONDON--(BUSINESS WIRE)---- $LIVN--LivaNova PLC will host a conference call to discuss its third quarter 2020 results on Thursday, October 29, 2020 at 12 p.m. London (8 a.m. EDT).

Zacks Investment Research - 5 months ago

LivaNova (LIVN) delivered earnings and revenue surprises of 50.00% and 6.10%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

Benzinga - 5 months ago

Shares of LivaNova (NASDAQ:LIVN) were unchanged after the company reported Q2 results.

Zacks Investment Research - 5 months ago

LivaNova (LIVN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Seeking Alpha - 8 months ago

LivaNova PLC (LIVN) CEO Damien McDonald on Q1 2020 Results - Earnings Call Transcript

Benzinga - 8 months ago

Shares of LivaNova (NASDAQ:LIVN) were unchanged at $56.37 after the company reported Q1 results.

Zacks Investment Research - 8 months ago

LivaNova (LIVN) delivered earnings and revenue surprises of -2.94% and 3.25%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

Zacks Investment Research - 10 months ago

LivaNova (LIVN) delivered earnings and revenue surprises of 5.26% and -1.54%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

Zacks Investment Research - 1 year ago

LivaNova (LIVN) delivered earnings and revenue surprises of 16.67% and -1.55%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

Zacks Investment Research - 1 year ago

LivaNova (LIVN) is aiming to reach out to more patients, with improved enrollment program.

Zacks Investment Research - 1 year ago

LivaNova (LIVN) delivered earnings and revenue surprises of 2.94% and 1.13%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

Zacks Investment Research - 1 year ago

Solid growth in emerging markets is expected to be an added positive this earnings season.

Other stocks mentioned: DXCM, HOLX, MASI, MCK
Seeking Alpha - 1 year ago

LivaNova PLC (LIVN) CEO Damien McDonald on Q1 2019 Results - Earnings Call Transcript

The Motley Fool - 1 year ago

These stocks lost ground even as the broader market posted solid gains.

The Motley Fool - 1 year ago

The medical-device company posted tepid preliminary first-quarter revenue.

About LIVN

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates in two segments, Cardiovascular (CV) and Neuromodulation (NM). The CV segment develops, produces, and sells cardiopulmonary products, including heart-lung machines, oxygenators, perfusion tubing sets, cannulae, and accessories, as well as related equipment and disposables for autotransfusion and autologous blood washing for neonatal, pediatric, and adult patients. It also provides surgical tissue and mechanical valve r... [Read more...]

Industry
Medical Devices
IPO Date
Feb 10, 1993
CEO
Damien McDonald
Employees
4,000
Stock Exchange
NASDAQ
Ticker Symbol
LIVN
Full Company Profile

Financial Performance

In 2019, LivaNova's revenue was $1.08 billion, a decrease of -2.06% compared to the previous year's $1.11 billion. Losses were -$155.18 million, -18.07% less than in 2018.

Financial Statements

Analyst Forecasts

According to 8 analysts, the average rating for LivaNova stock is "Buy." The 12-month stock price forecast is 73.67, which is an increase of 8.16% from the latest price.

Price Target
$73.67
(8.16% upside)
Analyst Consensus: Buy